What is AGGRENOX?

AGGRENOX is an FDA-approved prescription medication to lower the risk of stroke in people who have had either a TIA (transient ischemic attack or “mini-stroke”) or stroke due to a blood clot.

AGGRENOX is proven to be effective:

In a clinical study, AGGRENOX helped reduce the risk of stroke in patients who had a TIA or stroke due to a blood clot.

Over 90% of patients on AGGRENOX remained stroke-free (1493 out of a total of 1650).
Patients taking AGGRENOX twice daily were 22% less likely to have stroke than patients taking low-dose aspirin (25 mg twice daily) alone.

Learn about the study.

ESPS2 (European Stroke Prevention Study) was a 24-month study in which 6602 patients over the age of 18 had an ischemic stroke or TIA ("mini-stroke" or transient ischemic attack) within 3 months prior to entry.

Patients received treatment with either AGGRENOX (aspirin/extended-release dipyridamole); extended-release dipyridamole (200 mg alone); aspirin (25 mg alone); or a sugar pill (placebo) twice daily (morning and evening).

Taking AGGRENOX to Reduce Stroke Risk

AGGRENOX Stories: Watch real patient and doctor videos >GO NOW

Insight for Caregivers: Get important information that will help you take care of your loved one >LEARN MORE

Need help paying for AGGRENOX? Our patient assistance program may be able to help.

IMPORTANT SAFETY INFORMATION

EXPAND SAFETY INFORMATION

Please Note: You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all the pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible for, and disclaims any liability to, the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.

Notice and Healthcare Provider Information

The following information is intended only for healthcare professionals licensed and practicing in the United States and is designed to be an educational aid that supplements and draws upon the professional training, experience, and knowledge of such healthcare professionals.

Do you certify that you are a healthcare professional licensed and
practicing in the United States?

This flash element is not visible because you do not have Adobe^® Flash Player 9. Click here to download the latest version free of charge. This link is provided to you as a convenience. Boehringer Ingelheim Pharmaceuticals, Inc. does not control, and is not responsible for, the content of any linked page.

The information you submitted cannot be captured at this time due to routine maintenance on the website. Please try back later. We are sorry for the inconvenience.